• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利福平在阿尔茨海默病中的治疗作用。

Therapeutic role of rifampicin in Alzheimer's disease.

机构信息

Department of Neurology, Istanbul Medipol University, Istanbul, Turkey.

Department of Restorative and Regenerative Medicine, Istanbul Medipol University, Istanbul, Turkey.

出版信息

Psychiatry Clin Neurosci. 2018 Mar;72(3):152-159. doi: 10.1111/pcn.12637. Epub 2018 Feb 10.

DOI:10.1111/pcn.12637
PMID:29315976
Abstract

Rifampicin exerts significant brain protective functions in multiple experimental models. Here we summarize the underlying mechanisms of the neuroprotective and pro-cognitive effects of rifampicin that are mediated by its anti-inflammatory, anti-tau, anti-amyloid, and cholinergic effects. Beyond suggesting that rifampicin shows strong brain protective effects in preclinical models of Alzheimer's disease, we also provide substantial clinical evidence for the neuroprotective and pro-cognitive effects of rifampicin. Future neuroimaging studies combined with clinical assessment scores are the following steps to be taken in this field of research.

摘要

利福平在多种实验模型中发挥显著的脑保护功能。在这里,我们总结了利福平通过其抗炎、抗tau、抗淀粉样蛋白和胆碱能作用介导的神经保护和认知促进作用的潜在机制。除了表明利福平在阿尔茨海默病的临床前模型中显示出强烈的脑保护作用外,我们还为利福平的神经保护和认知促进作用提供了大量的临床证据。未来的神经影像学研究结合临床评估评分将是这一研究领域的下一步。

相似文献

1
Therapeutic role of rifampicin in Alzheimer's disease.利福平在阿尔茨海默病中的治疗作用。
Psychiatry Clin Neurosci. 2018 Mar;72(3):152-159. doi: 10.1111/pcn.12637. Epub 2018 Feb 10.
2
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.利福平是一种针对淀粉样β和tau 寡聚物的候选预防药物。
Brain. 2016 May;139(Pt 5):1568-86. doi: 10.1093/brain/aww042. Epub 2016 Mar 28.
3
The Multi-Target Drug M30 Shows Pro-Cognitive and Anti-Inflammatory Effects in a Rat Model of Alzheimer's Disease.多靶点药物M30在阿尔茨海默病大鼠模型中显示出促认知和抗炎作用。
J Alzheimers Dis. 2015;47(2):373-83. doi: 10.3233/JAD-143126.
4
Neuroprotective and Neurological/Cognitive Enhancement Effects of Curcumin after Brain Ischemia Injury with Alzheimer's Disease Phenotype.姜黄素对具有阿尔茨海默病表型的脑缺血损伤后的神经保护和神经认知增强作用。
Int J Mol Sci. 2018 Dec 12;19(12):4002. doi: 10.3390/ijms19124002.
5
Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.法舒地尔对 APP/PS1 转基因小鼠的多靶点治疗作用。
CNS Neurol Disord Drug Targets. 2017;16(2):199-209. doi: 10.2174/1871527315666160711104719.
6
Comparative study of the neuroprotective and nootropic activities of the carboxylate and amide forms of the HLDF-6 peptide in animal models of Alzheimer's disease.
J Psychopharmacol. 2016 Jan;30(1):78-92. doi: 10.1177/0269881115616393. Epub 2015 Dec 1.
7
Memory recuperative potential of rifampicin in aluminum chloride-induced dementia: role of pregnane X receptors.利福平对氯化铝诱导的痴呆的记忆恢复潜力:孕烷X受体的作用
Neuroscience. 2015 Mar 12;288:24-36. doi: 10.1016/j.neuroscience.2014.12.033. Epub 2014 Dec 27.
8
The nootropic and neuroprotective proline-containing dipeptide noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model.益智和具有神经保护作用的含脯氨酸二肽诺肽普特在阿尔茨海默病模型中可恢复空间记忆并增强对淀粉样蛋白的免疫反应性。
J Psychopharmacol. 2007 Aug;21(6):611-9. doi: 10.1177/0269881106071335. Epub 2006 Nov 8.
9
Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.亮蓝G可改善阿尔茨海默病动物模型的认知功能,并抑制淀粉样β蛋白诱导的海马神经元丝状伪足和树突棘丢失。
Neuroscience. 2014 Oct 24;279:94-101. doi: 10.1016/j.neuroscience.2014.08.036. Epub 2014 Sep 3.
10
RIFAMPICIN: an antibiotic with brain protective function.利福平:一种具有脑保护功能的抗生素。
Brain Res Bull. 2014 Aug;107:37-42. doi: 10.1016/j.brainresbull.2014.05.007. Epub 2014 Jun 4.

引用本文的文献

1
Systemic inflammation as a central player in the initiation and development of Alzheimer's disease.全身炎症是阿尔茨海默病发生和发展的核心因素。
Immun Ageing. 2025 Aug 21;22(1):33. doi: 10.1186/s12979-025-00529-5.
2
Microbiome Gut-Brain-Axis: Impact on Brain Development and Mental Health.微生物群-肠-脑轴:对大脑发育和心理健康的影响。
Mol Neurobiol. 2025 Apr 15. doi: 10.1007/s12035-025-04846-0.
3
Gut microbiota: A new window for the prevention and treatment of neuropsychiatric disease.肠道微生物群:预防和治疗神经精神疾病的新窗口。
J Cent Nerv Syst Dis. 2025 Feb 21;17:11795735251322450. doi: 10.1177/11795735251322450. eCollection 2025.
4
Neuroimaging techniques, gene therapy, and gut microbiota: frontier advances and integrated applications in Alzheimer's Disease research.神经成像技术、基因治疗与肠道微生物群:阿尔茨海默病研究中的前沿进展与综合应用
Front Aging Neurosci. 2024 Dec 3;16:1485657. doi: 10.3389/fnagi.2024.1485657. eCollection 2024.
5
Transcriptomics-based anti-tuberculous mechanism of traditional Chinese polyherbal preparation NiuBeiXiaoHe intermediates.基于转录组学的中药复方制剂牛贝消核中间体抗结核机制
Front Pharmacol. 2024 Sep 19;15:1415951. doi: 10.3389/fphar.2024.1415951. eCollection 2024.
6
Gut microbiota metabolites: potential therapeutic targets for Alzheimer's disease?肠道微生物群代谢产物:阿尔茨海默病的潜在治疗靶点?
Front Pharmacol. 2024 Sep 17;15:1459655. doi: 10.3389/fphar.2024.1459655. eCollection 2024.
7
Drugs with a negative impact on cognitive functions (part 3): antibacterial agents in patients with chronic kidney disease.对认知功能有负面影响的药物(第3部分):慢性肾病患者使用的抗菌药物
Clin Kidney J. 2024 Jun 14;17(8):sfae174. doi: 10.1093/ckj/sfae174. eCollection 2024 Aug.
8
Applied physiology: gut microbiota and antimicrobial therapy.应用生理学:肠道微生物群和抗菌治疗。
Eur J Appl Physiol. 2024 Jun;124(6):1631-1643. doi: 10.1007/s00421-024-05496-1. Epub 2024 Apr 29.
9
Alterations of Gastrointestinal Microbe Composition in Various Human Diseases and Its Significance in the Early Diagnosis of Diseases.多种人类疾病中胃肠道微生物组成的改变及其在疾病早期诊断中的意义
Cureus. 2024 Jan 17;16(1):e52435. doi: 10.7759/cureus.52435. eCollection 2024 Jan.
10
Interplay between microglia and environmental risk factors in Alzheimer's disease.阿尔茨海默病中,小胶质细胞与环境风险因素之间的相互作用。
Neural Regen Res. 2024 Aug 1;19(8):1718-1727. doi: 10.4103/1673-5374.389745. Epub 2023 Dec 11.